6Dam-Larsen S,Franzmann M,Andersen IB,et al.Long term prognosis of fatty liver:risk of chronic liver disease and death[J].Gut,2004,53(5):750-755.
7Marrero JA,Fontana RJ,Su GL,et al.NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States[J].Hepatology,2002,36(6):1349-1354.
8Browning J,Szczepaniak L,Dobbins R,et al.Prevalence of hepaticsteatosis in an urban population in the United States:impact of ethnicity[J].Hepatology,2004,40(6):1387-1395.
9Omagari K,Kadokawa Y,Masuda J,et al.Fatty liver in non-alcoholic non-overweight Japanese adults:incidence and clinical characteristics[J].J Gastroenterol Hepatol,2002,17(10):1098-1105.
10Ayturk S, Gursoy A, Kut A, et al. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol,2009,161 : 599-605.
